EGFR and Hypocalcemia: Regarding the anti-epidermal growth factor receptor (EGFR) monoclonal antibody panitumumab, electrolyte abnormalities, including hypomagnesemia, are reported among the characteristic side effects of anti-EGFR antibodies, while hypocalcemia is rarely reported [13].